GERAERTS M ET AL: "Upscaling of lentiviral vector production by tangential flow filtration" JOURNAL OF GENE MEDICINE, vol. 7, no. 10, October 2005 (2005-10), pages 1299-1310, XP002542493 ISSN: 1099-498X (B1)

WONG L-F ET AL: "Transduction patterns of pseudotyped lentiviral vectors in the nervous system" MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 9, no. 1, 1 January 2004 (2004-01-01), pages 101-111, XP008053109 ISSN: 1525-0016 (B1)

LU X ET AL: "Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol." THE JOURNAL OF GENE MEDICINE SEP 2004, vol. 6, no. 9, September 2004 (2004-09), pages 963-973, XP002542492 ISSN: 1099-498X (B1)

PAUL R W ET AL: "Increased viral titer through concentration of viral harvests from retroviral packaging lines" HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, vol. 4, 1 January 1993 (1993-01-01), pages 609-615, XP000653180 ISSN: 1043-0342 (B1)

RODRIGUES T ET AL: "Purification of retroviral vectors for clinical application: Biological implications and technological challenges" JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 127, no. 3, 1 December 2006 (2006-12-01), pages 520-541, XP005787045 ISSN: 0168-1656 (B1)

RODRIGUES T ET AL: "Scaleable purification process for gene therapy retroviral vectors" JOURNAL OF GENE MEDICINE, vol. 9, no. 4, April 2007 (2007-04), pages 233-243, XP002555552 ISSN: 1099-498X(print) 1521-2254(ele (B1)

ROHLL J B ET AL: "Design, production, safety, evaluation and clinical applications of nonprimate lentiviral vectors" METHODS IN ENZYMOLOGY, ACADEMIC PRESS INC, SAN DIEGO, CA, US, vol. 346, 1 January 2002 (2002-01-01), pages 466-500, XP009053525 ISSN: 0076-6879 (B1)

SEGURA M ET AL: "A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography" BIOTECHNOLOGY AND BIOENGINEERING, vol. 90, no. 4, May 2005 (2005-05), pages 391-404, XP002542495 ISSN: 0006-3592 (B1)

SEGURA M ET AL: "Downstream processing of oncoretroviral and lentiviral gene therapy vectors" BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, vol. 24, no. 3, 1 May 2006 (2006-05-01), pages 321-337, XP005362294 ISSN: 0734-9750 (B1)

SINN P L ET AL: "Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors - design, biosafety, and production" GENE THERAPY, vol. 12, no. 14, July 2005 (2005-07), pages 1089-1098, XP002555553 ISSN: 0969-7128 (B1)

US-A- 5 661 022 (B1)

WHITELAW C B A ET AL: "Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector" FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 571, no. 1-3, 30 July 2004 (2004-07-30), pages 233-236, XP004523343 ISSN: 0014-5793 (B1)

WO-A-2004/098531 (B1)

WO-A-2005/039643 (B1)

WO-A-2007/123961 (B1)

WO-A-2008/106644 (B1)

WO-A-96/21035 (B1)

KOLDEJ R ET AL: "Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production" JOURNAL OF GENE MEDICINE, vol. 7, no. 11, November 2005 (2005-11), pages 1390-1399, XP002542494 ISSN: 1099-498X (B1)